Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bahru A. Habtemariam

Tocilizumab for Treatment of Severe or Life-Threatening Chimeric Antigen Receptor T Cell-Induced Cytokine Release Syndrome—FDA Approval Summary

Biology of Blood and Marrow Transplantation

Transplantation

English

Related publications

Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy

Biology of Blood and Marrow Transplantation

Transplantation

English

Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy

British Journal of Haematology

English

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

Cancer Research

English

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma

Clinical Cancer Research

Cancer Research

English

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors

Molecular Therapy - Oncolytics

Cancer Research

Molecular Medicine

English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology

Cancer Research

Molecular Biology

English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology

English

Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma

Annals of Lymphoma

English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

Cancer Research

English